Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2000
06/02/2000WO2000031302A1 In situ binary synthesis of biologically effective molecules
06/02/2000WO2000031301A1 Association of trinucleotide repeat polymorphisms of the androgen receptor gene with disruptive disorders of childhood and aggressive or impulsive traits
06/02/2000WO2000031300A2 Genotyping by mass spectrometric analysis of short dna fragments
06/02/2000WO2000031299A2 Method for determining nucleotide sequences using arbitrary primers and low stringency
06/02/2000WO2000031298A1 Methods for detecting lower-frequency molecules
06/02/2000WO2000031297A1 Genetic markers which identify individuals who improve their diabetes status with exercise
06/02/2000WO2000031295A1 Method for distinguishing hla class i allele type
06/02/2000WO2000031294A2 Method for identifying cytosine methylation patterns in genomic dna
06/02/2000WO2000031293A1 Tnf-r2 complex polygenic disease gene marker
06/02/2000WO2000031292A1 Method for counting living cells
06/02/2000WO2000031291A1 Method for screening for substances which are activators, inhibitors or binders of pkb by the use of a substrate peptide and the use of the substrate peptide
06/02/2000WO2000031290A1 Methods and compositions for pain management
06/02/2000WO2000031289A1 Use of activated trap for screening for specific inhibitor of trap and method for aiding in the identification of a compound for use in the treatment of diseases or degenerative conditions resulting in increased bone resorption
06/02/2000WO2000031286A1 Adenoviral vector-mediated delivery of modified steroid hormone receptors and related products and methods
06/02/2000WO2000031275A1 Recombinant lysophosphatidic acid phosphatase
06/02/2000WO2000031273A2 Process for oxidising terpenes
06/02/2000WO2000031265A1 Urotensins ii of mammals and their uses
06/02/2000WO2000031263A2 Gtpase associated proteins
06/02/2000WO2000031259A1 Mammalian secretory protein zsig43
06/02/2000WO2000031253A2 Mutation of the parkin gene, compositions, methods and uses
06/02/2000WO2000031252A1 Human semaphorin 6a-1 (sema6a-a), a gene involved in neuronal development and regeneration mechanisms during apoptosis, and its use as a potential drug target
06/02/2000WO2000031240A1 Immortalized brain endothelial cells
06/02/2000WO2000031133A2 Potassium channel interactors and uses therefor
06/02/2000WO2000031127A2 Protein fragments for use in protein targeting
06/02/2000WO2000031115A1 Methods of identifying antigen gene sequences
06/02/2000WO2000031110A1 Identification of disease predictive nucleic acids
06/02/2000WO2000031108A1 Dna molecules encoding hg51, a g-protein-coupled receptor
06/02/2000WO2000031101A1 Method for the electrochemical detection of nucleic acid oligomer hybrids
06/02/2000WO2000030671A2 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
06/02/2000WO2000030662A1 Fabz
06/02/2000WO2000030628A2 Method of inhibiting angiogenesis
06/02/2000WO2000030590A2 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2
06/02/2000WO2000030425A2 Method of using pon-1 to decrease atheroma formation
06/02/2000WO2000014545A9 Multihued labels
06/02/2000WO2000014542A3 Diagnostic method for detecting disturbances of the pancreas
06/02/2000WO2000014283A3 Gene markers for chronic mucosal injury
06/02/2000WO2000014273A3 Differential genetic display technique and vector
06/02/2000WO2000011141A3 Trna binding domain
06/02/2000WO2000008213A9 Oligomers which inhibit expression of collagen genes
06/02/2000WO2000008177A3 Death associated kinase containing ankyrin repeats (dakar)
06/02/2000WO2000003024A9 Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon
06/02/2000WO1999066075A3 Diagnostic method based on quantification of extramitochondrial dna
06/02/2000WO1999064594A8 Genes and gene expression products that are differentially regulated in prostate cancer
06/02/2000WO1999063095A9 Nucleic acid vaccines for prevention of flavivirus infection
06/02/2000WO1999062942A3 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
06/02/2000WO1999061888A9 Microfabricated cell sorter
06/02/2000WO1999008485A9 Electric liquid heating vessels
06/02/2000CA2352606A1 Urotensins ii of mammals and their uses
06/02/2000CA2352599A1 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
06/02/2000CA2352560A1 Mammalian secretory protein zsig43
06/02/2000CA2352495A1 Human semaphorin 6a-1 (sema6a-a), a gene involved in neuronal development and regeneration mechanisms during apoptosis, and its use as a potential drug target
06/02/2000CA2352456A1 Primer extension methods utilizing donor and acceptor molecules for detecting nucleic acids
06/02/2000CA2352084A1 Immunostimulatory dna
06/02/2000CA2352042A1 Multiplex amplification of short tandem repeat loci
06/02/2000CA2351880A1 Dna molecules encoding hg51, a g-protein-coupled receptor
06/02/2000CA2351872A1 Use of activated trap for screening for specific inhibitor of trap and method for aiding in the identification of a compound for use in the treatment of diseases or degenerative conditions resulting in increased bone resorption
06/02/2000CA2351736A1 Methods of identifying antigen gene sequences
06/02/2000CA2351667A1 Method for modifying and identifying functional sites in proteins
06/02/2000CA2351567A1 Mutation of the parkin gene, compositions, methods and uses
06/02/2000CA2351419A1 Method and device for automated chromophore-assisted laser/light inactivation (cali)
06/02/2000CA2351365A1 Potassium channel interactors and uses therefor
06/02/2000CA2351361A1 Gtpase associated proteins
06/02/2000CA2351166A1 Method for screening for substances which are activators, inhibitors or binders of pkb by the use of a substrate peptide and the use of the substrate peptide
06/02/2000CA2351143A1 Method for identifying cytosine methylation patterns in genomic dna
06/02/2000CA2350756A1 Methods and apparatus for flow-through hybridization
06/02/2000CA2350749A1 Immortalized brain endothelial cells
06/02/2000CA2350599A1 Method of inhibiting angiogenesis
06/02/2000CA2350405A1 Method of using pon-1 to decrease atheroma formation
06/02/2000CA2349229A1 Prevention and treatment of amyloid-associated disorders
06/02/2000CA2345157A1 Method for electrochemically detecting nucleic acid oligomer hybrids
06/02/2000CA2319187A1 Measurement of hydride using chemiluminescent acridinium compounds
05/2000
05/31/2000EP1004873A1 Method and apparatus for identifying the function of biological molecules
05/31/2000EP1004677A1 Method for the direct, exponential amplification and sequencing of DNA molecules and its application
05/31/2000EP1004676A1 Methods for dna amplification and kits therefor
05/31/2000EP1004675A2 Methods of screening for nucleoside analogs that are incorporated by HIV reverse transcriptase and cause incorrect base pairing
05/31/2000EP1004670A2 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
05/31/2000EP1004593A2 Backbone modified oligonucleotide analogues
05/31/2000EP1004056A1 Multi parameter scanner
05/31/2000EP1004023A2 Rapid assay for simultaneous detection and differentiation of antibodies to hiv
05/31/2000EP1004022A1 Methods and compositions for overcoming resistance to biologic and chemotherapy
05/31/2000EP1004021A1 Determining the transforming capability of agents
05/31/2000EP1003917A1 Method and kit for hla class i typing dna
05/31/2000EP1003916A1 Antisense oligonucleotide compositions and methods for the modulation of jnk proteins
05/31/2000EP1003915A1 Amplification of nucleic acids
05/31/2000EP1003914A1 Methods and compositions for stripping nucleic acids
05/31/2000EP1003913A2 A method of removing nucleic acid contamination in amplification reactions
05/31/2000EP1003912A1 Surface-bound, bimolecular, double-stranded dna arrays
05/31/2000EP1003911A1 Method for the identification of synthetic cell- or tissue-specific transcriptional regulatory regions
05/31/2000EP1003910A1 Multiple functionalities within an array element and uses thereof
05/31/2000EP1003909A1 Reproductive and genetic screening samples of mutagenised animals
05/31/2000EP1003908A1 Nucleic acid archiving
05/31/2000EP1003907A1 Methods and kits for diagnosing alzheimer disease
05/31/2000EP1003906A1 Fluorescent polymeric sensor for the detection of creatinine
05/31/2000EP1003905A1 Electrochemical reporter system for detecting analytical immunoassay and molecular biology procedures
05/31/2000EP1003904A1 Color-encoding and in-situ interrogation of matrix-coupled chemical compounds
05/31/2000EP1003888A2 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
05/31/2000EP1003880A2 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
05/31/2000EP1003878A2 Hiv-1 group o antigens and uses thereof
05/31/2000EP1003877A2 Papilloma virus, agents for the detection thereof and for the therapy of the diseases caused by said virus
05/31/2000EP1003868A1 Genetic control of plant growth and development
1 ... 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 ... 3003